New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...

The SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already taking metformin. The primary aim was ...

The use of hybrid closed-loop systems in adults with T1D and comorbid depression and/or anxiety disorders appears to be safe and is linked to improved glycaemic outcomes, a real-world study finds.

Sciwind Biosciences Co., Ltd. ('Sciwind'), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's National ...

Adults with obesity and type 2 diabetes who underwent bariatric surgery had greater decreases in HbA1c and body weight than ...

Recent advances in diabetes detection may help to identify risk earlier. In this article, MNT discusses recent studies that ...

Recently, the results of the pivotal Phase III clinical trial (EECOH-1) of ecnoglutide injection, developed by Sciwind ...

While most people won't notice symptoms of the 'silent killer' until it is too late, there are still some signs to watch out for ...

Find the best breads for steady blood sugar, including whole grain, sprouted, rye, and some sourdough, plus simple tips for ...

A cardiologist has warned about three subtle symptoms of high blood pressure, the 'silent killer' condition that affects ...

The biopharmaceutical company released phase three clinical data for its type two diabetes treatment ecnoglutide in the peer-reviewed scientific journal.

Do you think diabetes or when you become pre-diabetic, it would have symptoms to show?Diabetes is defined as fasting blood glucose level of 126 mg/dL or higher, or a glycated hemoglobin level ...